GV
About GV
GV is a venture capital firm that supports innovative founders moving the world forward, with a focus on consumer, enterprise, life sciences, and frontier tech sectors.
Recent News
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
Syremis Therapeutics Raises $165M in Series A Financing
Pinterest Alternative Cosmos Is Looking to Redefine Visual Inspiration for Creatives
Lawhive Closes $60M Series B for Consumer Legal AI
Investors Share What to Remember While Raising a Series A
The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start
One-Time Hot Insurance Tech Ethos Poised to Be First Tech IPO of the Year
Synthesia Hits $4B Valuation, Lets Employees Cash Out
J&J Bets on Isomorphic for AI-Powered Drug Hunt
The Private Assets Held in Public Companies
AI-Powered Fragrance Company Osmo Raises $70 Million in Series B Funding
Syneron Raises $150m for Macrocyclics, and Other Financings
Gate Bioscience Raises $65M in Series B Financing
Paradigm Health Raises $78M in Series B Funding
Prudentia Sciences Secures $20M Series A Financing
Lawhive Raises $60M in Series B Funding
Mandiant’s Founder Just Raised $190M for His Autonomous AI Agent Security Startup
SolveAI Raises $50M to Help Employees Build Their Own Enterprise Software
EXCL: HMRC Signs £150k Deal for AI-Generated Comms and Training Videos
OpenEvidence, An AI-Powered ‘Brain Extender’ For Doctors, Doubles Valuation To $12B With $250M Series D
Midi Health Raises $100M in Series D Funding
Waymo Raises $16B Investment Round
Hana Health by DSS Imagetech Partners with Overture Life to Bring World-First Automated Egg-Freezing Technology to India
Censys Gets $70M to Scale Internet Intelligence Platform
Two Startups Want to Replace How AI Learns: One Just Raised $180M, Another Is Seeking up to $1B
Nerd Apply Raises $3.2M in Seed Funding
EpiBiologics Closes $107M Series B
Schwab Makes AI Push, With Client-Facing Agents To Roll Out in June
Navier Banks $5.6 Million Seed Funding
Recent Deals
Resistant AI Raises $25M Series B to Expand Fraud Prevention AI Internationally
Pelage Pharmaceuticals Closes $120M Series B Led by ARCH Venture Partners and GV
Odyssey Raises Series A Led by EQT Ventures
Synthesia Raises $200M in Latest Funding Round, Valuation Jumps to $4B
Gate Bioscience Secures $65M Series B Round Led by Forbion and Eli Lilly
Paradigm Health Secures $78M Series B Led by ARCH Venture Partners
EpiBiologics Raises $107M in Series B to Advance Protein-Degrading Cancer Drug
GV Leads $27M Series A Funding for Translucent, AI Healthcare Finance Platform
Syremes Therapeutics Secures $165M Series A to Advance Mental‑Health Drug Pipeline
Prudentia Sciences Raises $20M Series A Led by McKesson Ventures
Navier Secures $5.6M Seed Funding to Launch Autonomous Engineering Teams
Pelage Pharmaceuticals Raises $120M in Series B Co-Led by ARCH and GV
Midi Health Secures $100M Series D Funding Led by Goodwater Capital
OpenEvidence Raises $200M at $6B Valuation to Scale Medical AI
Counsel Health Raises $25M Series A Led by A16z and GV
Harvey Raises $300M Series E at $5B Valuation
Counsel Health Raises $25M Series A Led by A16z and GV